Stock option activity for the three months ended April 30, 2026 was as follows:


	Options Outstanding
	Outstanding Stock Options (in millions)	Weighted- Average Exercise Price		Aggregate Intrinsic Value (in millions)
Balance as of January 31, 2026	6	$	207.54




Options granted under all plans	1	180.69






Balance as of April 30, 2026	7	$	203.99	$	92
Vested or expected to vest	7	$	204.67	$	87
Exercisable as of April 30, 2026	6	$	205.53	$	48

Restricted stock activity for the three months ended April 30, 2026 was as follows:


	Restricted Stock Outstanding
	Outstanding (in millions)	Weighted Average Grant Date Fair Value		Aggregate Intrinsic Value (in millions)
Balance as of January 31, 2026	26	$	265.64
Granted - restricted stock units and awards	20	195.02
Granted - performance-based restricted stock units	1	204.63
Canceled	(2)	257.88
Vested and converted to shares	(5)	255.71
Balance as of April 30, 2026	40	$	230.36	$	7,038
Expected to vest	34			$	5,919

The aggregate expected stock-based compensation expense remaining to be recognized as of April 30, 2026 was as follows (in millions):


Fiscal Period:
Remaining nine months of fiscal 2027	$	2,822
Fiscal 2028	2,881
Fiscal 2029	2,019
Fiscal 2030	1,174
Fiscal 2031	131

Total stock-based compensation expense	$	9,027

The aggregate expected stock-based compensation expense remaining to be recognized reflects only outstanding stock awards as of April 30, 2026 and assumes no forfeiture activity and no changes in the expected level of attainment of performance share grants based on the Company’s financial performance relative to certain targets.

The Company’s Board of Directors (the “Board”) authorized a program to repurchase shares of the Company's common stock (the "Share Repurchase Program"), which commenced in August 2022. In February 2026, the Board authorized $50.0 billion in share repurchases under the Share Repurchase Program, which is inclusive of the accelerated share repurchase described below and replaces the previous remaining unpurchased authorization. The Share Repurchase Program does not have a fixed expiration date and does not obligate the Company to acquire any specific number of shares. Under the Share Repurchase Program, shares of common stock may be repurchased using a variety of methods, including privately negotiated and or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as part of accelerated share repurchases and other methods. The timing, manner, price and amount of any repurchases are determined by the Company in its discretion and depend on a variety of factors, including legal requirements, price and economic and market conditions. The Company accounts for treasury stock under the cost method.

In March 2026, the Company entered into accelerated share repurchase agreements (the “ASR Agreements”) with several financial institutions to repurchase an aggregate $25.0 billion of its common stock. Pursuant to the terms of the ASR Agreements, the Company made up-front payments totaling $25.0 billion and received an initial delivery of approximately 103 million shares of its common stock at an average price per share of $198.34. The initial share delivery represented approximately 80 percent of the total shares expected to be repurchased under the ASR Agreements. During the first quarter of fiscal 2027, the Company recorded $20.6 billion to treasury stock for the cost of the delivered shares as well as associated fees and excise taxes. A $4.6 billion reduction to additional paid-in capital was recorded for the unsettled portion of the ASR Agreements as forward contract components classified within stockholders’ equity.